期刊文献+

纤溶酶相关蛋白在急性髓性白血病血浆和骨髓中的表达 被引量:5

The expression of plasmin associated proteins in bone marrow and plasma in AML
下载PDF
导出
摘要 目的:观察髓性白血病及正常人骨髓单个核细胞及血浆中uPA、tPA、PAI的表达情况并探讨其临床意义。方法:用ELISA 法测定20 例急性髓性白血病及15 例正常人骨髓单个核细胞及血浆中uPA、tPA、PAI-1、PAI-2 抗原表达,同时用发色底物法测定血浆中tPA、uPA 和PAI-1 的活性。结果:骨髓中tPA 浓度白血病低于正常人( P< 0.01),血浆中相反。uPA 浓度骨髓及血浆中白血病均高于正常人( P< 0.001)。PAI-1 抗原测定两者骨髓及血浆均无差别。PAI-2 正常人骨髓中高于白血病( P< 0.01),血浆中相反。急性髓性白血病uPA、tPA和PAI-1 血浆活性均高于正常人。结论:急性髓性白血病骨髓中uPA 表达增高,说明白血病细胞主要表达uPA 为主,不产生tPA。tPA 的释放是由于血管内皮细胞受到白血病细胞损伤引起。在急性髓性白血病患者的出血机制与uPA、tPA 过度表达导致纤溶亢进有关,而且白血病早期浸润可能与uPA、PAI的表达有关。 Objective:To investigate the uPA,tPA,PAI Ⅰ PAI Ⅱ antigen expression in bone marrow manomuclei cell (MNC) and its plasma level in AML and normal subject;furthermore to explone its clinical importance.Method:Using ELISA to determinating uPA,tPA,PAI Ⅰ PAI Ⅱ antigen in bone marrow MNC and its plasma level in 20 AML and 15 normal subject using chromophoric substract method to measure the uPA tPA PAI Ⅰ activity.Result:The tPA and PAI Ⅱ exprescion in BM MNe in AML is lower than in normal subjects while plasma level of the two factor is higher in AMI the uPA in BM MNC and its plasma level are both higher in AML.PAI Ⅰ in BM MNC and its plasma level are the same in AML and normal subject.The tPA uPA,PAI 1 activity in AMI is higher than normal.Conclusion:The hemostasis mechanism in AML is associated with high level of uPA and tPA which inducing inueased fibrinolysis.uPA is predominatly expressed in the leukemia cells and the higher tPA is mainly released by the injuried vessel endethelial cells.
出处 《临床血液学杂志》 2000年第1期26-28,共3页 Journal of Clinical Hematology
关键词 白血病 急性 纤溶酶原激活剂 纤溶亢进 AML Plasminogen acitvator Plasminogen activator inhibitor Fbrinolysis
  • 相关文献

参考文献4

  • 1Bennett B,Booth N A,Cnoll,et al.Thebleeding disorder in acute promyelocytic leukaemia:fibrinolysis due to u-PA rather thandefibrination.Br J Haematol,1989,7:511~517
  • 2Tapiovaara H,Alitalo R,Stephens,et al.Abundant urokinase activity on the surface ofmononuclear ceels from blood and bone marrow of acute leukemia patients.Blood,1994,82:914~919
  • 3Tapiovaara H,Matikainen S,Hurme M,et al.Induction of differentiation ofpromyelocytic NB4 cells by retinoic acid is associated with rapid increase inurokinase activity subsequently downregulated by production of inhibitors.Blood,1994,83:1883~1889
  • 4Dano K,Andreasen P A,Grondahl-Hansea,et al.Plasminogen activation,tissuedegradation and cancer.Adv Cancer Res,1985,44:139~144 收稿 1999-06-28

同被引文献22

  • 1王静,汪洪毅,王伟.急性白血病患者血浆中可溶性尿激酶型纤溶酶原激活剂受体水平的检测[J].白血病.淋巴瘤,2006,15(1):44-45. 被引量:2
  • 2谢燕,王兆钺,张威,戴兰,白霞.白血病细胞纤溶活性及机制的研究[J].中国病理生理杂志,2007,23(2):250-253. 被引量:1
  • 3石岩,梅世昌.医学动物实验手册[M].中国农业出版社,21-30.
  • 4Devy L,Noel A, Baramova E, et al. Production and activation of matrix metalloprotease-9 (MMP 9) by HL-60 promyelocytic leukemia cells[J].Biochem Biophys Res Commun 1997,238(3) :842 -6.
  • 5Scherrer A,Wohlwend A,Kruithof Ek,et al.Plasminogen activation in human acute leukaemias[J].Br J Haematol,1999,105(4):920.
  • 6BlasiF,CamelietP uPAR a versatile signaling orchestrator[J].Nat Rev Mol Cell Biol,2002,3(12):932.
  • 7PlougM.Structure-function relationships in the interaction between the urokinase-tye plasminogen activator and its receptor[J].Curr Pham Des,2003,9(19):1499.
  • 8章静波.组织细胞培养技术[M].北京:人民卫生出版社.2002.109-1127.
  • 9Devy L, Noel A, Baramova E, et al. Production and activation of matrix metalloprotease-9 ( MMP-9 ) by HL-60 promyelocytie leukemia cells [J]. Bioehem Biophys Res Commun, 1997,238(3) :842-846.
  • 10Mustjoki S, Alitalo R, Stephens RW, et al. Plasminogen activation in human leukemia and in normal hematopoietic cells[J]. APMIS, 1999,107( 1 ) : 144-149.

引证文献5

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部